Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rupesh Parikh

Stocks Extend Weekly Losing Streak: Stock Market Today

Efforts to boost crude supplies did little to stem worries of rising oil prices and inflation ahead of next week's Fed meeting.

Stock Market Today: Nasdaq Nabs New High After Jobs Data

Stock Market Today: Nasdaq Nabs New High After Jobs Data

The S&P 500 also closed at its highest level ever, while the Dow Jones Industrial Average was pressured by another down day for UnitedHealth stock.

Ulta Beauty Stock Gets a Much-Needed Boost After Earnings

Ulta Beauty Stock Gets a Much-Needed Boost After Earnings

Beaten-down Ulta Beauty stock is notably higher Friday after the cosmetics retailer's strong earnings report and encouraging outlook.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dollar General, Dollar Tree, Five Below Q3 Earnings Preview: Can Discount Retailers Rebound Ahead Of Holidays?

Dollar General, Dollar Tree and Five Below all report quarterly results this week. A look at the estimates and what Placer.ai data shows.

Key Takeaways From Costco Wholesale Analyst Ratings

Analysts' ratings for Costco Wholesale (NASDAQ:COST) over the last quarter vary from bullish to bearish, as provided by 33 analysts.

Why Ulta Beauty Stock Is Still a Buy After Earnings

Ulta Beauty stock is falling Friday after disappointing earnings, but Wall Street isn't worried. Here's what you need to know.

Is Target Stock a Buy After Its Beat-And-Raise Quarter?

Target stock is soaring Wednesday after the discount retailer's blowout earnings report and analysts like what they're seeing. Here's what you need to know.

inkl

Read news from The Economist, FT, and more,
with one subscription

Alleged military secret leaker Jack Teixeira ordered detained ahead of trial

Tribune News Service

‘Never did I imagine that I would have to ration chemotherapy’

Nationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.

Tribune News Service

1

People

Chris Zaccarelli

Shantanu Narayen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Los Angeles Times

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

354,267 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play